The effect of sibutramine on energy expenditure and body composition in obese adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1409-1414

  Van Mil, Edgar G A H ^b   Westerterp, Klaas R ^a   Kester, Arnold D M ^a   Delemarre van De Waal, Henriette A ^b   Gerver, Willem J M ^c   Saris, Wim H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SIBUTRAMINE;

ABDOMINAL DISCOMFORT; ADOLESCENT; AGITATION; ARTHROPATHY; ARTICLE; BASAL METABOLIC RATE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSMENORRHEA; ENERGY EXPENDITURE; EXERCISE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEADACHE; HEART RATE; HUMAN; INCREASED APPETITE; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEIGHT CHANGE;

EID: 34147147143     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0264     Document Type: Article

References (28)

1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB 2003 Years of life lost due to obesity. JAMA 289:187-193
2. Molnar D 2005 New drug policy in childhood obesity. Int J Obes 29:S62-S65
3. Godoy-Matos A, Carraro L, Vieira A, Oliveira J, Guedes EP, Mattos L, Rangel C, Moreira RO, Coutinho W, Appolinario JC 2005 Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 90:1460-1465
4. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL 2003 Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 289:1805-1812
5. James PT, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF 2000 Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 356:2119-2125
6. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS 1998 Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 6:1-11
7. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A 1998 Thermogenic effects of sibutramine in humans. Am J Clin Nutr 68:1180-1186
8. Walsh KM, Leen E, Lean ME 1999 The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes 23:1009-1015
9. Gerver WJM, Bruin RD 1996 Paediatric morphometrics. Utrecht, The Netherlands: Wetenschappelijke uitgevery Bunge
10. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
11. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
12. Group IEW, ICH harmonised tripartite guideline. ICH-International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1996, http://www.emea. eu.int/pdfs/human/ich/013595en.pdf
13. Baecke JAH, Burema J, Frijters JER 1982 A short questionnaire for the measurement of habitual physical activity in epidemiolical studies. Am J Clin Nutr 36:936-942
14. Sallis JF, Patrick K 1994 Physical activity guidelines for adolescents: consensus statement. Pediatr Exercise Sci 6:302-314
15. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
16. Westerterp KR, Wouters L, Marken-Lichtenbelt WDv 1995 The Maastricht protocol for the measurement of body composition and energy expenditure with labeled water. Obes Res 3:49-57
17. Fredriks AM, Van Buren S, Wit JM, Verloove-Vanhorick SP 2000 Body index measurements in 1996-7 compared with 1980. Arch Dis Child 82:107-112
18. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M 1992 Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Lond) 82:687-693
19. Van Marken Lichtenbelt W, Fogelholm M 1999 Body composition. In: Westerterp-Plantenga MS, Steffens AB, Tremblay A, eds. Regulation of food intake and energy expenditure. Milan: EDRA
20. Van Mil EGAH, Westerterp KR, Gerver WJ, Curfs LM, Schrander-Stumpel CT, Kester AD, Saris WH 1999 Energy expenditure at rest and during sleep in children with Prader-Willi syndrome explained by body composition. Am J Clin Nutr 71:752-756
21. Van Mil E, Westerterp K, Kester A, Saris W 2001 Energy expenditure in adolescence: a multicenter analysis of the effect of gender and body composition. Arch Dis Child 85:73-78
22. Schoffelen PFM, Westerterp KR, Saris WHM, Hoor FT 1997 A dual-respiration chamber system with automated calibration. J Appl Physiol 83:2064-2072
23. Van Mil EG, Westerterp KR, Kester AD, Curfs LM, Gerver WJ, Schrander-Stumpel CT, Saris WH 2000 Activity related energy expenditure in children and adolescents with Prader-Willi syndrome. Int J Obes Relat Metab Disord 24:429-434
24. Schoeller D 1999 The shortage of O-18 water. Obes Res 7:519
25. Tounian P, Frelut ML, Parlier G, Abounaufal C, Aymard N, Veinberg F, Fontaine JL, Girardet JP 1999 Weight loss and changes in energy metabolism in massively obese adolescents. Int J Obes Relat Metab Disord 23:830-837
26. Golozoubova V, Strauss F, Malmlof K 2006 Locomotion is the major determinant of sibutramine-induced increase in energy expenditure. Pharmacol Biochem Behav 83:517-527
27. Ioannides-Demos LL, McNeil JJ, Proietto J 2005 Pharmacotherapy for obesity. Drugs 65:1391-1418
28. Sondheimer JM, Silverman A 1995 Gastrointestinal tract. In: Hay WW, Groothuis JR, Hayward AR, Levin MJ, eds. Current-pediatric diagnosis and treatment. Norwalk, CT: Appleton, Lange; 633-63